Stability-indicating thin-layer chromatographic method for quantitative determination of ribavirin.
暂无分享,去创建一个
I. Darwish | H. Askal | A. Khedr | R. Mahmoud
[1] Sarfaraz K Niazi. Stability Data Package for Registration Applications in Climatic Zones III and IV , 2009 .
[2] I. Darwish,et al. Application of inorganic oxidants to the spectrophotometric determination of ribavirin in bulk and capsules. , 2006, Journal of AOAC International.
[3] I. Darwish,et al. Simple fluorimetric method for determination of certain antiviral drugs via their oxidation with cerium (IV). , 2005, Farmaco.
[4] M. Breadmore,et al. Determination of ribavirin in human serum and plasma by capillary electrophoresis , 2004, Electrophoresis.
[5] J. McHutchison,et al. New therapies for chronic hepatitis C virus infection , 2004, Current gastroenterology reports.
[6] Karen M. Alsante,et al. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals , 2003 .
[7] L. Yeh,et al. A sensitive and specific method for the determination of total ribavirin in human red blood cells by liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatographic science.
[8] A. Bruchfeld,et al. Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography. , 2000, Therapeutic drug monitoring.
[9] A. M. Battaglia,et al. Combination Therapy with Interferon and Ribavirin in the Treatment of Chronic Hepatitis C Infection , 2000, The Annals of pharmacotherapy.
[10] F. Aweeka,et al. High-Performance Liquid Chromatographic Determination of Ribavirin in Whole Blood To Assess Disposition in Erythrocytes , 1999, Antimicrobial Agents and Chemotherapy.
[11] C. Lakshmi,et al. Application of sodium metaperiodate for the determination of ribavirin in pharmaceutical formulations. , 1998, Talanta.
[12] S. Ahuja. Impurities evaluation of pharmaceuticals , 1998 .
[13] M. Chevallier,et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation , 1997, Hepatology.
[14] C. Blot,et al. Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin , 1997, Journal of viral hepatitis.
[15] C. Riley,et al. Chromatographic methods for the bioanalysis of antiviral agents. , 1990, Journal of chromatography.
[16] M. Kagnoff,et al. Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin , 1983, Antimicrobial Agents and Chemotherapy.
[17] J. B. Jerome. The United States Pharmacopeia, ed 20; The National Formulary , 1981 .
[18] D. Dieterich,et al. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV. , 1999, Seminars in liver disease.
[19] J. Mcginity. Drug Stability: Principles and Practices , 1991 .